HB917
Compounding pharmacies; use of bulk drug substances, recordkeeping.
Status:
In House
Latest Action:
Jan. 27, 2026
House: Continued to next session in Health and Human Services (Voice Vote)
Chief Patron:
Rodney Willett (D)
Session:
2026 Regular Session
Summary
As Introduced. Board of Pharmacy; compounding pharmacies; use of bulk drug substances; recordkeeping.
Establishes additional requirements for when pharmacists may use bulk drug substances in compounding and specifies prohibitions on pharmacist use of (i) bulk drug substances that were withdrawn or removed from the market for reasons of safety and effectiveness or were covered by an investigational new drug application and not approved ... (More) and (ii) compounded drug products that are essentially a copy of commercially available drug products. The bill permits the Board of Pharmacy to request records of all compounded drug products and requires pharmacists to furnish such records within 48 hours of such request or within a reasonable time as determined by the Board. The bill also permits the Board of Pharmacy to submit any information related to investigations, disciplinary proceedings, or inspection of a licensee to the National Association of Boards of Pharmacy. (Less)-
Bill History
- 01/13/2026 - House: Prefiled and ordered printed; Offered 01-14-2026 26105003D
- 01/13/2026 - House: Referred to Committee on Health and Human Services
- 01/26/2026 - House: Placed on Health and Human Services Agenda
- 01/26/2026 - House: Fiscal Impact Statement from Department of Planning and Budget (HB917)
- 01/27/2026 - House: Continued to next session in Health and Human Services (Voice Vote)
